• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含1,2,3-三唑的N-酰基扎那米韦类似物作为强效神经氨酸酶抑制剂的设计与合成

Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors.

作者信息

Das Anindya, Adak Avijit K, Ponnapalli Kalyankumar, Lin Chien-Hung, Hsu Kai-Cheng, Yang Jinn-Moon, Hsu Tsu-An, Lin Chun-Cheng

机构信息

Department of Chemistry, National Tsing Hua University, 101, Section 2, Kuang-Fu Road, Hsinchu 30013, Taiwan.

Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.

出版信息

Eur J Med Chem. 2016 Nov 10;123:397-406. doi: 10.1016/j.ejmech.2016.07.064. Epub 2016 Jul 28.

DOI:10.1016/j.ejmech.2016.07.064
PMID:27487569
Abstract

The design of potent metabolically stable neuraminidase (NA) inhibitors represents an attractive approach for treating influenza virus infection. In this study, we describe the exploitation of the 150-cavity in the active site of group 1 NA for the design, synthesis, and in vitro evaluation of new triazole-containing N-acyl derivatives related to Zanamivir. Inhibition studies with influenza virus NAs of group 1 (H1N1) and group 2 (H3N2) revealed that several of them are good inhibitors, with IC50 values in the low nanomolar (2.3 nM-31 nM) range. Substituents that form stable van der Waals interaction with the 150-cavity residues play crucial roles in NA inhibition as demonstrated by the potency of 6a (H1N1 IC50 = 2.3 nM, and H3N2 IC50 = 2.9 nM). Docking studies indicated that the cyclohexane-substituted triazole ring extended toward the hydrophobic region in the active site of group 1 NA in open form. The high potency observed for inhibitor 6a may be attributable to the highly favorable hydrophobic interactions in this region.

摘要

设计高效代谢稳定的神经氨酸酶(NA)抑制剂是治疗流感病毒感染的一种有吸引力的方法。在本研究中,我们描述了利用1型NA活性位点中的150腔来设计、合成和体外评估与扎那米韦相关的含新三唑的N-酰基衍生物。对1型(H1N1)和2型(H3N2)流感病毒NA的抑制研究表明,其中几种是良好的抑制剂,IC50值在低纳摩尔(2.3 nM - 31 nM)范围内。如6a的效力所示,与150腔残基形成稳定范德华相互作用的取代基在NA抑制中起关键作用(H1N1的IC50 = 2.3 nM,H3N2的IC50 = 2.9 nM)。对接研究表明,环己烷取代的三唑环以开放形式向1型NA活性位点的疏水区域延伸。观察到抑制剂6a具有高效力可能归因于该区域高度有利的疏水相互作用。

相似文献

1
Design and synthesis of 1,2,3-triazole-containing N-acyl zanamivir analogs as potent neuraminidase inhibitors.含1,2,3-三唑的N-酰基扎那米韦类似物作为强效神经氨酸酶抑制剂的设计与合成
Eur J Med Chem. 2016 Nov 10;123:397-406. doi: 10.1016/j.ejmech.2016.07.064. Epub 2016 Jul 28.
2
Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities.酰胍扎那米韦衍生物的合成及其作为神经氨酸酶抑制剂的活性评价。
Org Biomol Chem. 2013 Jun 28;11(24):3943-8. doi: 10.1039/c3ob40624e.
3
Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs.作为强效抗流感药物的取代扎那米韦衍生物的分子建模与先导设计
BMC Bioinformatics. 2016 Dec 22;17(Suppl 19):512. doi: 10.1186/s12859-016-1374-1.
4
Design, synthesis and biological evaluation of novel zanamivir derivatives as potent neuraminidase inhibitors.新型扎那米韦衍生物作为强效神经氨酸酶抑制剂的设计、合成及生物学评价
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3622-3629. doi: 10.1016/j.bmcl.2018.10.040. Epub 2018 Oct 26.
5
Synthesis of C-4-modified zanamivir analogs as neuraminidase inhibitors and their anti-AIV activities.C-4 位修饰扎那米韦类似物的合成及其抗 AIV 活性。
Eur J Med Chem. 2012 Aug;54:764-70. doi: 10.1016/j.ejmech.2012.06.033. Epub 2012 Jun 29.
6
Structure-based design and synthesis of C-1- and C-4-modified analogs of zanamivir as neuraminidase inhibitors.基于结构的扎那米韦 C-1 和 C-4 修饰类似物的设计与合成及其作为神经氨酸酶抑制剂的研究
J Med Chem. 2013 Feb 14;56(3):671-84. doi: 10.1021/jm3009713. Epub 2013 Jan 30.
7
Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.酰基胍型奥司他韦羧酸盐衍生物作为强效神经氨酸酶抑制剂的发现。
Bioorg Med Chem. 2017 May 15;25(10):2772-2781. doi: 10.1016/j.bmc.2017.03.052. Epub 2017 Mar 27.
8
Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.设计、合成及 4-噻唑啉酮衍生物作为流感神经氨酸酶抑制剂的生物活性评价。
Eur J Med Chem. 2021 Mar 5;213:113161. doi: 10.1016/j.ejmech.2021.113161. Epub 2021 Jan 12.
9
Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.甲型禽流感病毒H5N1亚型神经氨酸酶与奥司他韦、扎那米韦、帕拉米韦及其膦酸酯类似物复合物的动态行为
J Chem Inf Model. 2009 Oct;49(10):2323-32. doi: 10.1021/ci900277r.
10
Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.2009-2010 年和 2010-2011 年流感季节日本大流行和季节性流感病毒的神经氨酸酶抑制剂敏感性特征。
Antiviral Res. 2013 Sep;99(3):261-9. doi: 10.1016/j.antiviral.2013.06.003. Epub 2013 Jun 17.

引用本文的文献

1
Antiviral Activity of (1,9a)-1-[(1,2,3-Triazol-1-yl)methyl]octahydro-1-quinolizines from the Alkaloid Lupinine.来自生物碱羽扇豆碱的(1,9a)-1-[(1,2,3-三唑-1-基)甲基]八氢-1-喹嗪的抗病毒活性
Molecules. 2024 Dec 5;29(23):5742. doi: 10.3390/molecules29235742.
2
Antiviral Compounds to Address Influenza Pandemics: An Update from 2016-2022.应对流感大流行的抗病毒化合物:2016-2022 年的最新进展。
Curr Med Chem. 2024;31(18):2507-2549. doi: 10.2174/0929867331666230907093501.
3
Direct access to various C3-substituted sialyl glycal derivatives from 3-iodo-sialyl glycals.
从 3-碘代唾液酸糖基到各种 C3-取代的唾液酰基糖甘衍生物的直接途径。
Org Biomol Chem. 2021 Dec 1;19(46):10169-10173. doi: 10.1039/d1ob01977e.
4
Five Novel Non-Sialic Acid-Like Scaffolds Inhibit In Vitro H1N1 and H5N2 Neuraminidase Activity of Influenza a Virus.五种新型非唾液酸样支架抑制甲型流感病毒 H1N1 和 H5N2 神经氨酸酶活性。
Molecules. 2020 Sep 16;25(18):4248. doi: 10.3390/molecules25184248.
5
Development of effective anti-influenza drugs: congeners and conjugates - a review.抗流感药物的研发:同系物和缀合物——综述。
J Biomed Sci. 2019 Oct 23;26(1):84. doi: 10.1186/s12929-019-0567-0.